Optimizes cell therapy development using spatial biology, AI, and pooled screening to rapidly discover and rank superior therapies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Waypoint Bio optimizes cell therapy development by leveraging spatial biology profiling, AI-powered models, and pooled screening to rapidly test and rank thousands of potential therapies. The company uses advanced computer vision and generative AI to achieve deep phenotyping at the single-cell level, accelerating the discovery of superior cell therapy designs for diseases such as solid tumors.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Waypoint Bio Management Team
Investors
Fifty Years
Hummingbird Ventures
Recode Ventures
Waypoint Bio Valuations & Financials
View real-time NPM data on Waypoint Bio stock including daily Waypoint Bio stock price estimates, valuation history, and historical share price information. Access Waypoint Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Waypoint Bio pricing across six independent market signals. Looking for private company due diligence data sources on Waypoint Bio? Get in touch to learn more.
Similar Companies
like Waypoint Bio
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Nanoscale Components
Industrials
Designs and manufactures advanced electronic materials and components, specializing in nanotechnology solutions for semiconductor devices.
ELSA Speak
Consumer
Delivering AI-driven conversational coaching with real-time feedback on pronunciation, fluency, intonation, and vocabulary in a gamified mobile app.
Workhelix
AI & Machine Learning
Provides enterprises with AI opportunity assessment and project tracking through task-based analysis for actionable insights.
Plivo
Enterprise Software
Enables developers that build communication experiences via voice, messaging, and AI agents using scalable, programmable APIs.
Vimcal
Enterprise Software
Simplifies calendar management with quick scheduling, time zone coordination, and AI-powered assistance.
Garwood Medical Devices
Healthcare & Life Sciences
Delivers patient monitoring and respiratory care equipment to improve clinical outcomes and safety.
FAQ
We have answers
Waypoint Bio stock does not trade on public stock exchanges. Waypoint Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Waypoint Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Waypoint Bio Stock does not trade on public stock exchanges. In order to sell Waypoint Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Waypoint Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Waypoint Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Waypoint Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Waypoint Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Waypoint Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Waypoint Bio is a private company and has not had an IPO. There is currently no Waypoint Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Waypoint Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
